MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway

F-C Cui1, Y Chen, X-Y Wu

  • 1Department of Clinical Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, Jinshui District, Zhengzhou City, Henan, P.R. China. facaichn@163.com.

Abstract

Insights

MicroRNA493-5p (miR-493-5p) suppresses colorectal cancer (CRC) progression by inhibiting the PI3K-Akt-FoxO3a pathway. This microRNA is downregulated in CRC and its restoration reduces cancer cell proliferation, migration, and invasion.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNA493-5p (miR-493-5p) is implicated in cancer cell proliferation and migration.
  • The specific role and mechanism of miR-493-5p in colorectal cancer (CRC) remain largely unelucidated.

Purpose of the Study:

  • To investigate the function and mechanism of miR-493-5p in colorectal cancer (CRC) progression.
  • To determine the molecular targets and signaling pathways regulated by miR-493-5p in CRC.

Main Methods:

  • Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) for miR-493-5p expression analysis in CRC tissues and cell lines.
  • Cell proliferation, migration, and invasion assays (colony formation, transwell, wound-healing) following miR-493-5p mimic transfection or PI3K agonist treatment.
  • Luciferase reporter assays, Western blotting, and immunofluorescence to assess the miR-493-5p/PI3K interaction and downstream signaling (PI3K, Akt, FoxO3a).

Main Results:

  • MiR-493-5p expression was significantly downregulated in CRC tissues and cell lines, correlating with disease progression.
  • Overexpression of miR-493-5p inhibited CRC cell proliferation, migration, and invasion.
  • MiR-493-5p directly targets PI3K, leading to decreased expression of PI3K, Akt, and FoxO3a proteins. PI3K agonist treatment counteracted the suppressive effects of miR-493-5p.

Conclusions:

  • MiR-493-5p acts as a tumor suppressor in colorectal cancer.
  • The miR-493-5p-mediated suppression of CRC progression occurs through inhibition of the PI3K-Akt-FoxO3a signaling pathway.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K